Filing Flows › Thermo Fisher Scientific (TMO) › R&D spending
Thermo Fisher Scientific (TMO) R&D spending by quarter
Thermo Fisher Scientific's R&D spending was $348M in Q3 2026 (third quarter 2026), -4% from Q2 2026. Over the last 7 quarters it ranged from $336M (Q1 2026) to $364M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $348M | -4% | +0.6% |
| Q2 2026 | $364M | +8% | +3% |
| Q1 2026 | $336M | -6% | -2% |
| Q4 2025 | $356M | +3% | — |
| Q3 2025 | $346M | -2% | — |
| Q2 2025 | $352M | +3% | — |
| Q1 2025 | $342M | — | — |
Q3 2026 at a glance
Thermo Fisher Scientific, Q3 2026: revenue $12.1B (+9% year over year), operating margin 18.6%, net earnings $1.7B, operating cash flow $2.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Thermo Fisher Scientific's R&D spending?
Thermo Fisher Scientific's R&D spending was $348M in Q3 2026 (third quarter 2026), -4% from Q2 2026.
How has Thermo Fisher Scientific's R&D spending changed?
Over the last 7 quarters it ranged from $336M (Q1 2026) to $364M (Q2 2026).
Q3 2026 results → · How Thermo Fisher Scientific makes money →